"Located on the campus of Suburban Community Hospital, Fox Chase East Norriton offers patients access to Fox Chase’s specialized team of surgical oncologists, radiation oncologists, hematologists/oncologists and genetic counselors, allowing individuals to be treated closer to home."

During the past decade, Fox Chase Cancer Center - East Norriton Hospital Outpatient Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" #1 sponsor was "ECOG-ACRIN Cancer Research Group" with 6 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" are "Stage IV Lung Cancer AJCC v8" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" are "Drug" (18 trials), "Other" (12 trials), "Procedure" (7 trials), "Radiation" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (6 trials), "Computed Tomography" (5 trials), "Cisplatin" (4 trials), "Paclitaxel" (4 trials) and "Positron Emission Tomography" (4 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" are 17 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center". undefined are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".